Review Article Research advances of secretory proteins in malignant tumors Na Zhang, Jiajie Hao, Yan Cai, Mingrong Wang State Key Laboratory of Molecular Oncology, Center for Cancer Precision Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China Correspondence to: Mingrong Wang. State Key Laboratory of Molecular Oncology, Center for Cancer Precision Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Email:
[email protected]; Jiajie Hao. State Key Laboratory of Molecular Oncology, Center for Cancer Precision Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Email:
[email protected]. Abstract Secretory proteins in tumor tissues are important components of the tumor microenvironment. Secretory proteins act on tumor cells or stromal cells or mediate interactions between tumor cells and stromal cells, thereby affecting tumor progression and clinical treatment efficacy. In this paper, recent research advances in secretory proteins in malignant tumors are reviewed. Keywords: Secretory protein; tumor microenvironment; stromal cells; tumor progression; drug resistance Submitted Aug 26, 2020. Accepted for publication Jan 05, 2021. doi: 10.21147/j.issn.1000-9604.2021.01.12 View this article at: https://doi.org/10.21147/j.issn.1000-9604.2021.01.12 Introduction breast cancer, colorectal cancer, glioma, ovarian cancer, osteosarcoma, pancreatic cancer, etc. Secretory proteins can be produced by tumor cells or stromal cells.